| Year | Firm | Client | Income | Doc |
|---|---|---|---|---|
| 2021 3rd Quarter - Report |
VENN STRATEGIES | AMERICAN DIABETES ASSOCIATION | $50,000 | |
| 2021 3rd Quarter - Report |
VENN STRATEGIES | AMERICAN SOCIETY OF HEALTH SYSTEM PHARMACISTS | $30,000 | |
| 2021 2nd Quarter - Report |
VENN STRATEGIES | AMERICAN DIABETES ASSOCIATION | $80,000 | |
| 2021 2nd Quarter - Report |
VENN STRATEGIES | AMERICAN SOCIETY OF HEALTH SYSTEM PHARMACISTS | $20,000 | |
| 2021 Registration |
VENN STRATEGIES | AMERICAN SOCIETY OF HEALTH SYSTEM PHARMACISTS | — | |
| 2021 1st Quarter - Report |
VENN STRATEGIES | AMERICAN DIABETES ASSOCIATION | $80,000 | |
| 2020 4th Quarter - Report |
VENN STRATEGIES | AMERICAN DIABETES ASSOCIATION | $80,000 | |
| 2020 4th Quarter - Report |
VENN STRATEGIES | REGENERON PHARMACEUTICALS, INC. | $100,000 | |
| 2020 3rd Quarter - Report |
VENN STRATEGIES | REGENERON PHARMACEUTICALS, INC. | $130,000 | |
| 2020 3rd Quarter - Report |
VENN STRATEGIES | AMERICAN DIABETES ASSOCIATION | $110,000 |